We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Success Factors of ACHEMA 2012 Include Highest Ever International Participation

By LabMedica International staff writers
Posted on 09 Jul 2012
The 5-day ACHEMA 2012 exhibition congress for the chemical engineering, environmental protection, and biotechnology process industries (Frankfurt, Germany) concluded on June 22, after 167,000 participants learned about a broad range of products and services presented by 3,773 exhibitors on a 136,400 m² exhibition area with a very well received new layout of halls. More...


Popular exhibition groups included Pumps, Compressors, Valves and Fittings, Instrumentation, Control and Automation Techniques, Laboratory and Analytical Techniques, "Thermal, "Mechanical Processes, and Pharmaceutical, Packaging and Storage Techniques. In all fields, particular attention was devoted to the major themes of energy and bio-economics.

With a proportion of foreign exhibitors of almost 50%, coming from 56 countries, the ACHEMA was more international than ever before, reflecting that in these highly globalised industries ACHEMA is a leading event. “Globalisation does not just mean Europeans and Americans going to Asia – increasingly, Asian exhibitors and visitors are coming to Europe," noted Dr. Thomas Scheuring, CEO of DECHEMA Ausstellungs-GmbH. This was also evident in that more than 200 Chinese and 150 Indian companies presented their ranges. Still, numerous European and US companies once again also used the opportunity to present their innovations.

The congress included 900 talks and numerous events of various types. Aspects expected to occupy the process industry in the coming future included energy generation and storage, and biomass processing. Talks on materials science, bionics, and chemistry parks also met with a great response. "We made the right selection of focus topics," said Prof. Dr. Kurt Wagemann, Executive Director of DECHEMA e.V.

Exhibitors and visitors expressed high satisfaction. "It was a very successful show for us; considerably better than in 2009, even better than 2006 before the crisis happened,” said Friedbert Klefenz, Bosch Packaging Technology. Karsten Just of Bartec Holding noted, "More noticeable than the numbers is the fact that the quality of the visitors was very high." And according to the results of the visitor survey, more than 83% of the visitors judged the quality of the ACHEMA as "good“ or "very good“.

The 31st ACHEMA will take place starting June 15, 2015, in Frankfurt and the 9th AchemAsia on May 13-16, 2013, in Beijing (China).

Related Links:

ACHEMA



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.